RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 143 pages - $1,495
Non-Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 622 pages - $1,495
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
Jan 2010 - 84 pages - $2,000
Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jun 2011 - 72 pages - $2,000
Blood Cancer Drug Discoveries: what the future holds
Apr 2008 - 245 pages - $2,265
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
CNS Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Burkitt Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Communications del
Therapeutic target
Oncology del
Lymphoma del
Hodgkin's lymphoma del
Geographic location
Asia del
Pakistan del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us